坎普托塞辛在癌症治疗中的应用:纳米乳液的当前挑战和新兴策略
Heber Uriel Pérez-Ortega1, Rubén Ricardo Córdova-Espíritu2, Sebastian Cano-Serrano1
1División de Estudios de Posgrado e Investigación (DEPI), Tecnológico Nacional de México (TecNM), Instituto Tecnológico de Celaya (ITC), Celaya 38010, Guanajuato, Mexico.
Pharmaceutics
|November 27, 2025
概括
坎普托塞辛 (CPT) 和它的类似物通过抑制Topoisomerase I (Topo I) 在癌症治疗中表现有前途. 纳米粒子输送系统的目的是改进CPT.
科学领域:
- 药理学和纳米医学的研究.
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 坎普托素 (CPT) 是一种天然的类化合物,通过抑制Topoisomerase I (Topo I) 具有强大的抗增殖活性.
- 由于溶解性差和乳环不稳定性,CPT的临床使用受到限制,从而降低了疗效.
- 经批准的类似物,如伊利诺特干和托波特干,在药物耐药性和副作用方面面临挑战.
研究的目的:
- 审查坎普托西因 (CPT) 和其癌症治疗类型的近期进展.
- 探索基于纳米粒子的传递系统,以提高CPT的稳定性,生物可用性和有效性.
- 概述CPT纳米医学开发中的翻译挑战.
主要方法:
- 关于坎普托塞辛 (CPT) 和其类型的文献综述.
- 对纳米粒子输送平台 (纳米乳液,脂质体,ADC) 的分析.
- 讨论CPT的作用机制和临床限制.
主要成果:
- 纳米医学策略显示出增强CPT稳定性和生物可用性的潜力.
- 像纳米乳液,脂质体和ADC这样的输送系统可以提高CPT的有效性.
- 尽管取得了进展,但可扩展性,药理动力学和监管方面的挑战仍然存在.
结论:
- 基于纳米粒子的输送系统是克服CPT在癌症治疗方面的局限性的有希望的策略.
- 优化CPT治疗可能会提高治疗效果并降低毒性.
- 解决翻译挑战对于CPT纳米药物的临床成功至关重要.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Drugs that Destabilize Microtubules
3.6K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K
Cancer Vaccines
936
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
936


